Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
Derek Q PhanRay ZadeganMing-Sum LeePublished in: Journal of the American Geriatrics Society (2021)
There were no differences in all-cause mortality and non-fatal MI with invasive revascularization (either PCI or CABG) versus medical therapy alone in patients ≥80 years old with SIHD. Large randomized trials focusing on older patients are warranted to guide clinical practice in this growing population.
Keyphrases
- coronary artery bypass grafting
- percutaneous coronary intervention
- end stage renal disease
- clinical practice
- healthcare
- ejection fraction
- coronary artery disease
- chronic kidney disease
- newly diagnosed
- prognostic factors
- atrial fibrillation
- stem cells
- heart failure
- bone marrow
- middle aged
- patient reported outcomes
- community dwelling